Home › Circulating Neoplastic Cells
Circulating Neoplastic Cells clinical trials recruiting in the U.S.
8 studies for Circulating Neoplastic Cells are recruiting participants at sites across the United States.
Cities with the most studies
By state
Recently updated studies
ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials
RecruitingObservational study
Ages 18 and older · Men · Updated Nov 6, 2026 · NCT06141993Circulating Tumor Cell Analysis in Patients With Localized Prostate Cancer Undergoing Prostatectomy
RecruitingObservational study
Ages 18 and older · Men · Updated Oct 20, 2026 · NCT01961713Biomarkers to Detect Endocrine Therapy Resistance
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT06067503Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated May 1, 2026 · NCT02838836Collection and Measurement of Biomarkers in Prostate Cancer Radiotherapy Patients
RecruitingObservational study
Ages 30 and older · Men · Updated Mar 4, 2026 · NCT02997709Liquid Biopsy for Hepatocellular Carcinoma Molecular Characterization After Y90
RecruitingObservational study
Ages 18 and older · All sexes · Updated Dec 26, 2025 · NCT07303712Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)
RecruitingObservational study
Ages 18 to 85 · All sexes · Updated Mar 19, 2025 · NCT06717243In Vivo Liquid Biopsy of Melanoma (Cytophone)
RecruitingHealthy volunteers welcome
Ages 18 to 80 · All sexes · Updated Mar 11, 2025 · NCT06488365From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.